MorphoSys Announces Clinical Milestone in Cancer Program with Bayer Schering Pharma

News   Sep 08, 2009

 
MorphoSys Announces Clinical Milestone in Cancer Program with Bayer Schering Pharma
 
 
 

RELATED ARTICLES

Advanced Prostate Cancer: EMA Approves Abiraterone Combined With Hormone Therapy as First-line Treatment

News

The prostate cancer drug abiraterone has been approved by the European Medicines Agency in combination with standard hormone therapy for use as a first-line treatment for advanced prostate cancer.

READ MORE

Diabetes Drug Could Be Re-purposed to Help End Transplant Rejection

News

A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs.

READ MORE

What Makes Cancer Cells Metastasize?

News

Metastatic spread of tumor cells from one location in the body to another is the cause of 90 percent of cancer-related deaths.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE